590 filings
Page 13 of 30
8-K/A
3zsc7iv
12 Jun 20
Financial Statements and Exhibits
4:31pm
CORRESP
7z7kg 77vg
12 Jun 20
Correspondence with SEC
12:00am
UPLOAD
5mn2p 62qbn
11 Jun 20
Letter from SEC
12:00am
UPLOAD
5hl14hx olu27xqwxzz5
3 Jun 20
Letter from SEC
12:00am
DEFA14A
mggmw4i2yppg1zegqz
2 Jun 20
Additional proxy soliciting materials
7:30am
8-K
x2i7lm94tqpgmi70
27 May 20
Other Events
4:31pm
D
41u7w2e
15 May 20
$22.57M in equity / options, sold $22.57M, 149 investors
1:22pm
CORRESP
01h37wfv1krjft9vapcz
15 May 20
Correspondence with SEC
12:00am
SC 13D
l869ei5en13j9qxqtb
14 May 20
9 METERS BIOPHARMA / OrbiMed Israel BioFund GP Limited Partnership ownership change
5:25pm
UPLOAD
akppp0qq5r
13 May 20
Letter from SEC
12:00am
8-K
roe 8ut5l
11 May 20
9 Meters Biopharma, Inc Receives Thorough QT Study Waiver by FDA for Larazotide Being Studied for Celiac Disease
4:36pm
8-K
ptes59
8 May 20
9 Meters Biopharma, Inc Announces the Closing of Naia Rare Diseases Acquisition
4:15pm
8-K
h9xjy31wyyck6oak
5 May 20
9 Meters Biopharma Hosting Research & Development Day
4:33pm
4
3ps vx5qrpkjddrpx99r
5 May 20
Change in insider ownership
4:20pm
4
jmx ftzkeh2wsj
5 May 20
INNOVATE BIOPHARMACEUTICALS / Nissim Darvish ownership change
4:18pm
4
85rpiry8
4 May 20
INNOVATE BIOPHARMACEUTICALS / Nissim Darvish ownership change
7:40pm